Year-end Sale % OFF 
Abstract
The guidelines issued recently by the European Organisation for Research and Treatment of Cancer (EORTC) for the management of cancer-related anaemia [1] are a welcome addition to previously published guidelines [2]. In recent years the impact of anaemia on patient outcomes and quality of life (QOL) has been highlighted vis-à-vis the availability of effective anaemia treatments beyond blood transfusion. The recognition that anaemia and resulting fatigue are not inevitable consequences of cancer treatment, and that performance status and QOL are improved when anaemia is controlled, is a great stride forward.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
